7TM Pharma, a spin-off company of University of Copenhagen discovers and develops compounds acting on 7TM (seven transmembrane segment) receptors, also known as G-protein coupled receptors or GPCRs. The company’s drug discovery approach is Site-Directed Drug Discovery®. 7TM Pharma’s main therapeutic area of focus is obesity, but it also has programs in inflammation/allergy, therapeutic angiogenesis and cardiovascular diseases. The products of the company include TM30338, TM30335, CRTH2 antagonist etc.